Physician profile
Samer Kais
NPI 1851501613
$1,663.80
in general payments reported to CMS, 2019-2025
12 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $905 · 2021: $189 · 2022: $12.57 · 2023: $409 · 2024: $24.42 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $691.31 | 2019-2025 | |
| Tela Bio, INC. | $187.73 | 2019 | |
| Medline Industries Lp | $157.71 | 2023 | |
| Kci USA, INC. | $155.16 | 2019-2023 | Abthera Advance |
| Integra Lifesciences Corporation | $139.48 | 2021 | |
| Aroa Biosurgery Incorporated | $127.34 | 2023 | |
| Kls-Martin L.P. | $51.24 | 2023 | |
| Pfizer INC. | $43.17 | 2019-2021 | |
| Allergan, INC. | $32.64 | 2021-2022 | |
| Davol INC. | $30.68 | 2019 | |
| Haemonetics Corporation | $24.42 | 2024 | Teg6s Hemostasis System |
| Acell, INC. | $22.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Kais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.